Infection Control Today

Research Suggests New Way to Ensure Effectiveness of TB Treatment

A UT Southwestern Medical Center study using a sophisticated “glass mouse” research model has found that multidrug-resistant tuberculosis (TB) is more likely caused in patients by speedy drug metabolism rather than inconsistent doses, as is widely believed. If the study ...More

December 28, 2011

Posted in News, Infections & Pathogens

Tuberculosis Market Projected to be Worth Almost $27 Million by 2018

A new report from Research and Markets and GlobalData, "Tuberculosis Infection - Pipeline Assessment and Market Forecasts to 2018," indicates that the global tuberculosis (TB) infection market was worth $38.3 million in 2010. It is expected to decline at a compound annual ...More

December 19, 2011

Posted in News, Infections & Pathogens

Diagnosis of Tuberculosis is Increased in Postpartum Women

The incidence of tuberculosis (TB) diagnosis is significantly increased in mothers postpartum, suggesting a potential new population to target for screening, according to a new UK-wide cohort study. In the joint study between the Health Protection Agency and the University ...More

December 9, 2011

Posted in News, Infections & Pathogens

Discordance Among Commercially-Available Diagnostics for Latent TB Infection

In populations with a low prevalence of tuberculosis (TB), the majority of positives with the three tests commercially available in the U.S for the diagnosis of TB are false positives, according to a new study. "We compared commercially available tests for latent ...More

December 9, 2011

Posted in News, Infections & Pathogens

Study Leads to Simpler Therapy for Treating Latent Tuberculosis

Research led by Timothy Sterling, MD, professor of medicine at Vanderbilt University Medical Center, has led to an important change in CDC recommendations in the regimen for prevention of the centuries-old scourge, tuberculosis (TB). Sterling’s work is published in the Dec. ...More

December 8, 2011

Posted in News, Infections & Pathogens

Report Highlights Impact of Medical Misdiagnosis of TB and Fungal Infection

Researchers have discovered that more than 1 million people worldwide diagnosed with tuberculosis (TB) go on to develop an incurable but manageable fungal infection which is usually left untreated because it is mistaken for a recurrence of the disease. In a new report ...More

December 1, 2011

Posted in News, Infections & Pathogens

Vaccine Targeting Latent TB Enters Clinical Testing

Statens Serum Institut and Aeras today announce the initiation of the first Phase I clinical trial of a new candidate TB vaccine designed to protect people latently infected with TB from developing active TB disease. The trial is being conducted by the South African ...More

December 1, 2011

Posted in News

Researchers Validate Effectiveness of Tuberculosis Drug Target that Could Shorten Treatment Time

In research at SRI International, scientists evaluating new drug targets against tuberculosis (TB) recently validated the preclinical effectiveness of a target that could rapidly eliminate infections and potentially shorten treatment time. The new drug target is a protein ...More

November 29, 2011

Posted in News, Infections & Pathogens

Contract Awarded to Oxford Diagnostic Laboratories for T-SPOT TB Testing

Oxford Immunotec, Inc. announces that the National Acquisition Center of the Department of Veterans Affairs has awarded a Federal Supply Schedule contract to Oxford Diagnostic Laboratories for T-SPOT.TB testing. This contract will be effective from Nov. 1, 2011 through Oct. ...More

November 9, 2011

Posted in News, Infections & Pathogens

Research Shows Decrease in Observed Rate of TB During an Economic Recession

The incidence of tuberculosis (TB) in the U.S. is reported as being on the decrease, however untreated infected people act as a reservoir for disease. Any pool of the world's population harboring this disease gives cause for concern, especially since the BCG vaccine is only ...More

November 7, 2011

Posted in News, Infections & Pathogens

ANTIMICROBIAL PRODUCTS	DISINFECTION/STERILIZA...
DISPOSABLE PRODUCTS	INFECTION CONTROL
LATEX-FREE PRODUCTS	More Options...

Tuberculosis

Galleries

ICT Poll

Most Popular Articles

Buyer's Guide

Resources

Free Email Updates

featured links

First Name	Last Name
E-Mail